Success Metrics

Clinical Success Rate
95.0%

Based on 134 completed trials

Completion Rate
95%(134/141)
Active Trials
11(7%)
Results Posted
27%(36 trials)
Terminated
7(4%)

Phase Distribution

Ph phase_4
4
2%
Ph not_applicable
11
7%
Ph early_phase_1
2
1%
Ph phase_2
20
12%
Ph phase_1
115
69%
Ph phase_3
14
8%

Phase Distribution

117

Early Stage

20

Mid Stage

18

Late Stage

Phase Distribution166 total trials
Early Phase 1First-in-human
2(1.2%)
Phase 1Safety & dosage
115(69.3%)
Phase 2Efficacy & side effects
20(12.0%)
Phase 3Large-scale testing
14(8.4%)
Phase 4Post-market surveillance
4(2.4%)
N/ANon-phased studies
11(6.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.8%

134 of 146 finished

Non-Completion Rate

8.2%

12 ended early

Currently Active

11

trials recruiting

Total Trials

166

all time

Status Distribution
Active(16)
Completed(134)
Terminated(12)
Other(4)

Detailed Status

Completed134
Terminated7
Recruiting7
Not yet recruiting5
Withdrawn5
unknown4

Development Timeline

Analytics

Development Status

Total Trials
166
Active
11
Success Rate
95.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.2%)
Phase 1115 (69.3%)
Phase 220 (12.0%)
Phase 314 (8.4%)
Phase 44 (2.4%)
N/A11 (6.6%)

Trials by Status

terminated74%
recruiting74%
not_yet_recruiting53%
withdrawn53%
unknown42%
completed13481%
active_not_recruiting42%

Recent Activity

Clinical Trials (166)

Showing 20 of 166 trialsScroll for more
NCT06253715Phase 3

Shortened Regimen for Drug-susceptible TB in Children

Recruiting
NCT05556746Phase 2

Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB

Active Not Recruiting
NCT03672630Phase 2

Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease

Completed
NCT07357610Phase 1

An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants

Recruiting
NCT03012529Phase 4

Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics

Completed
NCT04951986Phase 3

Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis

Active Not Recruiting
NCT06489431Phase 3

Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement

Active Not Recruiting
NCT07242781Phase 1

A Study to Evaluate the Effect of Itraconazole and Rifampin on the Drug Levels of AR-LDD (BMS-986365) in Healthy Adult Male Participants

Recruiting
NCT05592223Phase 1

Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines

Completed
NCT04606537Phase 1

Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects

Completed
NCT07253688Phase 3

Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus

Recruiting
NCT07018635Phase 1

A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants

Completed
NCT05766267Phase 2

Short-course Regimens for the Treatment of Pulmonary Tuberculosis

Active Not Recruiting
NCT02563327Phase 3

Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis

Completed
NCT05338489Phase 1

A Study of Effects of Itraconazole and Rifampin on Selpercatinib (LY3527723) in Healthy Participants

Completed
NCT06222372Not Applicable

Novel Interventions and Diagnostic Tests for Leprosy

Recruiting
NCT04921943Phase 4

Hypertonic Saline for MAC

Recruiting
NCT03301038Phase 2

Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria

Recruiting
NCT05057949Phase 1

A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants

Completed
NCT06835465Phase 1

A Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Divarasib in Healthy Participants

Completed

Drug Details

Intervention Type
DRUG
Total Trials
166